NCT06034210

Brief Summary

This study evaluates the effectiveness of the Zoles customised 3D-printed insoles to mitigate running-related pain among frequent recreational runners who participate in regular Park Run activities. All participants will have their feet scanned, after which half of the participants will be provided with customised 3D-printed insoles, while the other half will receive no intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for not_applicable pain

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

September 16, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2024

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 25, 2024

Completed
Last Updated

November 26, 2024

Status Verified

November 1, 2024

Enrollment Period

4 months

First QC Date

September 4, 2023

Last Update Submit

November 25, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Running-related Pain

    Change in running-related pain from baseline to follow-up during the trial period. Pain is scored on a numeric rating scale from 0 - 10 (0 = No pain at all, 10 = Extremely painful; Salaffi et al., 2004)

    10 weeks

Secondary Outcomes (10)

  • Global Rating of Change (GRoC) in overall daily pain and discomfort

    10 weeks

  • Running-related foot/footwear comfort

    10 weeks

  • 5k-completion time

    10 weeks

  • Running-related injuries

    10 weeks

  • Time-loss

    10 weeks

  • +5 more secondary outcomes

Other Outcomes (6)

  • Participants achieving MCID reduction in pain

    10 weeks

  • Time until MCID reduction in pain

    10 weeks

  • Change among participants with high baseline pain

    10 weeks

  • +3 more other outcomes

Study Arms (2)

ZOLES insoles

EXPERIMENTAL

Participants allocated to the intervention group will receive customised 3D-printed insoles (Zoles ApS, Espergærde, DK-3060, Denmark) to mitigate running-related pain and discomfort. Being a pragmatic trial, all participants are permitted to continue or initiate any usual care of their choice.

Device: Customised 3D-printed insoles

Do-as-usual

NO INTERVENTION

Participants allocated to the control group are a "do-as-usual" comparator. This implies, that the participants can treat and prevent running-related pain and discomfort in any way they wish, except using the Zoles 3D-printed insoles.

Interventions

Based on measurements from the 3D scanning procedure, and factoring in individual data such as age, weight, and activity preferences, custom insoles are designed using the ZOLA software. The insoles are then 3D-printed by Zoles ApS in Espergærde (Denmark), using BCN3D printers (Barcelona, Spain) and a TPU (Thermoplastic Polyurethane) filament material from Recreus (Alicante, Spain). The printed insoles are tailored for optimal support, performance, and comfort, with varying densities for areas like the arch and heel. They are finished with an OnSteam® microfiber cover for added durability and comfort. The insoles are intended for regular insertion into participants' shoes to align with their unique biomechanical needs. (Information translated and adapted from: https://www.zoles.eu/da/processen-bag-saalerne/)

Also known as: Zoles insoles
ZOLES insoles

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant is ≥ 35 years old at commencement of trial
  • Participant can read, speak and understand English
  • Participant can receive e-mails and complete online questionnaires
  • Participant is a frequent runner who participate in regular Park Runs
  • Participant is capable of running at commencement of trial

You may not qualify if:

  • Individuals with severe foot deformities
  • Individuals with uncontrolled diabetes with foot complications, or other conditions that might interfere with their ability to safely use the insoles and participate in running activities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Mary's University, Faculty of Sport, Technology and Health Sciences

Twickenham, London, TW1 4SX, United Kingdom

Location

Related Publications (1)

  • Ibrahim S, Djurtoft C, Mellor R, Thorborg K, Lysdal FG. The effectiveness of customised 3D-printed insoles on perceived pain, comfort, and completion time among frequent Park Runners: Study protocol for a pragmatic randomised controlled trial (The ZOLES RCT). Foot (Edinb). 2024 Mar;58:102068. doi: 10.1016/j.foot.2024.102068. Epub 2024 Feb 6.

    PMID: 38350194BACKGROUND

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Filip Gertz Lysdal, MSc, PhD

    Faculty of Sport, Technology and Health Sciences, St Mary's University, United Kingdom

    STUDY DIRECTOR
  • Suleyman Ibrahim, MEd

    Faculty of Sport, Technology and Health Sciences, St Mary's University, United Kingdom

    PRINCIPAL INVESTIGATOR
  • Chris Djurtoft, PT, MSc

    Department of Clinical Medicine, Aalborg University, Denmark

    STUDY CHAIR
  • Rik Mellor, MSc

    Faculty of Sport, Technology and Health Sciences, St Mary's University, United Kingdom

    STUDY CHAIR
  • Kristian Thorborg, PT, MSc, PhD

    Sports Orthopaedic Research Center-Copenhagen (SORC-C), Department of Orthopaedic Surgery, Copenhagen University Hospital, Amager-Hvidovre, Denmark

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2023

First Posted

September 13, 2023

Study Start

September 16, 2023

Primary Completion

January 2, 2024

Study Completion

November 25, 2024

Last Updated

November 26, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations